Michal Šimíček

1.8k total citations · 1 hit paper
29 papers, 1.1k citations indexed

About

Michal Šimíček is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Michal Šimíček has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Hematology and 6 papers in Oncology. Recurrent topics in Michal Šimíček's work include Multiple Myeloma Research and Treatments (9 papers), Ubiquitin and proteasome pathways (8 papers) and Protein Degradation and Inhibitors (5 papers). Michal Šimíček is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Ubiquitin and proteasome pathways (8 papers) and Protein Degradation and Inhibitors (5 papers). Michal Šimíček collaborates with scholars based in Czechia, United States and Belgium. Michal Šimíček's co-authors include David Komander, Tobias Wauer, Alexander F. Schubert, Anna Sablina, Roman Hájek, Tomáš Jelı́nek, Matouš Hrdinka, Jane L. Wagstaff, P.R. Elliott and Martin A. Michel and has published in prestigious journals such as Nature, Nature Communications and The EMBO Journal.

In The Last Decade

Michal Šimíček

27 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanism of phospho-ubiquitin-induced PARKIN activation

2015 366 citations Tobias Wauer, Michal Šimíček et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michal Šimíček Czechia	13	821	339	284	132	132	29	1.1k
Ho-Chou Tu United States	8	861 1.0×	128 0.4×	167 0.6×	152 1.2×	120 0.9×	9	1.1k
Ninib Baryawno Sweden	16	586 0.7×	258 0.8×	292 1.0×	32 0.2×	213 1.6×	35	1.1k
Antony Letai United States	11	545 0.7×	94 0.3×	303 1.1×	81 0.6×	104 0.8×	11	840
Colin E.J. Pritchard Netherlands	18	1.0k 1.2×	102 0.3×	350 1.2×	122 0.9×	98 0.7×	34	1.3k
Katsuhiro Sasaki Japan	14	987 1.2×	222 0.7×	352 1.2×	258 2.0×	615 4.7×	23	1.5k
Natalie Meyer Canada	5	1.2k 1.4×	70 0.2×	351 1.2×	106 0.8×	108 0.8×	7	1.5k
Neelam Shirsat India	22	692 0.8×	87 0.3×	193 0.7×	85 0.6×	174 1.3×	53	1.1k
Jean‐Philippe Brosseau Canada	14	604 0.7×	104 0.3×	304 1.1×	95 0.7×	248 1.9×	24	1.2k
Serge Carillo France	17	975 1.2×	140 0.4×	314 1.1×	295 2.2×	110 0.8×	35	1.4k
Richard Lilischkis Germany	12	679 0.8×	138 0.4×	252 0.9×	97 0.7×	82 0.6×	16	974

Countries citing papers authored by Michal Šimíček

Since Specialization

Citations

This map shows the geographic impact of Michal Šimíček's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Šimíček with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Šimíček more than expected).

Fields of papers citing papers by Michal Šimíček

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Šimíček. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Šimíček. The network helps show where Michal Šimíček may publish in the future.

Co-authorship network of co-authors of Michal Šimíček

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Šimíček. A scholar is included among the top collaborators of Michal Šimíček based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Šimíček. Michal Šimíček is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Steklov, Mikhail, Hyunbum Jang, Raj Nayan Sewduth, et al.. (2024). K128 ubiquitination constrains RAS activity by expanding its binding interface with GAP proteins. The EMBO Journal. 43(14). 2862–2877. 8 indexed citations

Nenarokov, Serafim, Tereza Ševčíková, Jan Vrána, et al.. (2024). Insights into Biological Mechanisms Responsible for Egression of Circulating Tumor Plasma Cells (CTCs) in Multiple Myeloma. Blood. 144(Supplement 1). 3270–3270. 1 indexed citations

Žihala, David, Alexander Vdovin, Tereza Ševčíková, et al.. (2023). Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling. International Journal of Molecular Sciences. 24(6). 5623–5623. 11 indexed citations

Vdovin, Alexander, et al.. (2023). Length-Dependent Translation Efficiency of ER-Destined Proteins. Current Issues in Molecular Biology. 45(8). 6717–6727. 1 indexed citations

Žihala, David, Tereza Ševčíková, Jan Vrána, et al.. (2023). Insight into the mechanism of CD34⁺ cell mobilisation impairment in multiple myeloma patients treated with anti‐CD38 therapy. British Journal of Haematology. 204(4). 1439–1449. 4 indexed citations

Celichowski, Piotr, Zuzana Chyra, Michal Šimíček, et al.. (2023). Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility. Journal of Translational Medicine. 21(1). 197–197. 30 indexed citations

Vdovin, Alexander, Tomáš Jelı́nek, David Žihala, et al.. (2022). The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma. Nature Communications. 13(1). 6820–6820. 16 indexed citations

Hrdinka, Matouš, Ryszard Smolarczyk, Tomasz Cichoń, et al.. (2021). Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment. Cells. 10(5). 967–967. 12 indexed citations

Hrdinka, Matouš, Michal Šimíček, Tomáš Jelı́nek, et al.. (2020). A Bird’s-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers. Cancers. 12(5). 1333–1333. 10 indexed citations

10.

Jelı́nek, Tomáš, Matouš Hrdinka, Juli R. Bagó, et al.. (2020). Intercellular Mitochondrial Transfer in the Tumor Microenvironment. Cancers. 12(7). 1787–1787. 38 indexed citations

11.

Jelı́nek, Tomáš, Michal Šimíček, Dana Šalounová, et al.. (2018). Cytarabine + G-CSF is more effective than cyclophosphamide + G-CSF as a stem cell mobilization regimen in multiple myeloma. Bone Marrow Transplantation. 54(7). 1107–1114. 10 indexed citations

12.

Mihályová, Jana, Tomáš Jelı́nek, Kateřina Growková, et al.. (2018). Venetoclax: A new wave in hematooncology. Experimental Hematology. 61. 10–25. 72 indexed citations

13.

Morgan, Michael T., Marcello Clerici, Kateřina Growková, et al.. (2018). Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins. EMBO Reports. 19(10). 41 indexed citations

14.

Baietti, Maria Francesca, Michal Šimíček, Layka Abbasi Asbagh, et al.. (2016). OTUB 1 triggers lung cancer development by inhibiting RAS monoubiquitination. EMBO Molecular Medicine. 8(3). 288–303. 84 indexed citations

15.

Michel, Martin A., P.R. Elliott, Kirby N. Swatek, et al.. (2015). Assembly and Specific Recognition of K29- and K33-Linked Polyubiquitin. Molecular Cell. 58(1). 95–109. 165 indexed citations

16.

Wauer, Tobias, Michal Šimíček, Alexander F. Schubert, & David Komander. (2015). Mechanism of phospho-ubiquitin-induced PARKIN activation. Nature. 524(7565). 370–374. 366 indexed citations breakdown →

17.

Polakovičová, Iva, Lubica Dráberová, Michal Šimíček, & Petr Dráber. (2014). Multiple Regulatory Roles of the Mouse Transmembrane Adaptor Protein NTAL in Gene Transcription and Mast Cell Physiology. PLoS ONE. 9(8). e105539–e105539. 13 indexed citations

18.

Šimíček, Michal, Sam Lievens, Mathias Laga, et al.. (2013). The deubiquitylase USP33 discriminates between RALB functions in autophagy and innate immune response. Nature Cell Biology. 15(10). 1220–1230. 77 indexed citations

19.

Kalev, Peter, Michal Šimíček, Iria Vázquez, et al.. (2012). Loss of PPP2R2A Inhibits Homologous Recombination DNA Repair and Predicts Tumor Sensitivity to PARP Inhibition. Cancer Research. 72(24). 6414–6424. 103 indexed citations

20.

Koffer, Anna, et al.. (2010). The transmembrane adaptor protein NTAL signals to mast cell cytoskeleton via the small GTPase Rho. European Journal of Immunology. 40(11). 3235–3245. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact